Dr. Emily Curran, MD
Claim this profileUniversity of Cincinnati Cancer Center-UC Medical Center
Expert in Leukemia
Studies Myeloid Leukemia
14 reported clinical trials
48 drugs studied
Area of expertise
1Leukemia
Global LeaderTP53 positive
T315I negative
BCR-ABL1 positive
2Myeloid Leukemia
TP53 positive
T315I negative
t(8;21) negative
Affiliated Hospitals
Clinical Trials Emily Curran, MD is currently running
Venetoclax + ASTX727
for Chronic Myelomonocytic Leukemia
This trial is testing if a combination of two drugs, ASTX727 and venetoclax, is more effective than ASTX727 alone in treating certain bone marrow cancers. It focuses on patients with CMML and MDS/MPN who have too many immature blood cells. ASTX727 helps produce normal blood cells and kills abnormal ones, while venetoclax blocks a protein that cancer cells need to survive. Venetoclax is an anticancer drug used to treat lymphomas and leukemias, but it has severe side effects.
Recruiting1 award Phase 2
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
More about Emily Curran, MD
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Emily Curran, MD has experience with
- Cytarabine
- Gilteritinib
- Daunorubicin
- Venetoclax
- SNDX-5613
- Rituximab
Breakdown of trials Emily Curran, MD has run
Leukemia
Myeloid Leukemia
Acute Myeloid Leukemia
Lymphoblastic Leukemia-Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emily Curran, MD specialize in?
Emily Curran, MD focuses on Leukemia and Myeloid Leukemia. In particular, much of their work with Leukemia has involved TP53 positive patients, or patients who are T315I negative.
Is Emily Curran, MD currently recruiting for clinical trials?
Yes, Emily Curran, MD is currently recruiting for 7 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Emily Curran, MD has studied deeply?
Yes, Emily Curran, MD has studied treatments such as Cytarabine, Gilteritinib, Daunorubicin.
What is the best way to schedule an appointment with Emily Curran, MD?
Apply for one of the trials that Emily Curran, MD is conducting.
What is the office address of Emily Curran, MD?
The office of Emily Curran, MD is located at: University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio 45219 United States. This is the address for their practice at the University of Cincinnati Cancer Center-UC Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.